|
| 变量 |
(总
) |
生存(
) |
死亡(
) |
价值 |
|
| 人口特征 |
| 性,(%) |
|
|
|
0.008 |
| 女 |
107 (16) |
83 (15) |
24 (26) |
|
| 男性 |
549 (84) |
482 (85) |
67 (74) |
|
| 年龄、y |
64.00 (74) |
63.00(51岁,73) |
70.00 (59,78) |
< 0.001 |
| 吸烟,(%) |
453 (69) |
396 (70) |
57 (63) |
0.192 |
| 周末入院时,(%) |
248 (38) |
205 (36) |
43 (47) |
0.059 |
| 延迟,(%) |
167 (25) |
133 (24) |
34 (37) |
0.007 |
| 血管危险因素 |
| 高血压,(%) |
380 (58) |
326 (58) |
54 (59) |
0.857 |
| 糖尿病,(%) |
121 (18) |
98 (17) |
23日(25) |
0.096 |
| 中风史,(%) |
35 (5) |
30日(5) |
5 (5) |
1 |
| 慢性肾病,(%) |
152 (23) |
122 (22) |
30 (33) |
0.024 |
| 临床数据 |
| 人力资源、节拍/分钟 |
80 (72、92) |
80.00 (72、91) |
85 (73、106) |
0.003 |
| SBP毫米汞柱 |
124 (108、140) |
127 (110、143) |
111 (92、129) |
< 0.001 |
| 菲律宾,毫米汞柱 |
80 (68、91) |
80 (70、92) |
74 (85) |
< 0.001 |
| Shock_index |
0.65 (0.55,0.77) |
0.64 (0.54,0.75) |
0.75 (0.61,1.04) |
< 0.001 |
| 心电图描记的数据 |
| 低,(%) |
300 (46) |
263 (47) |
37 (41) |
0.351 |
| 前,(%) |
322 (49) |
276 (49) |
46 (51) |
0.851 |
| 其他的,(%) |
21日(3) |
16日(3) |
5 (5) |
0.194 |
| 右心室,(%) |
7 (1) |
6 (1) |
1 (1) |
1 |
| 实验室考试入学 |
| 白细胞,109/ L |
11.27 (8.60,14.19) |
10.97 (8.34,13.57) |
13.92 (10.56,19.51) |
< 0.001 |
| 嗜中性粒细胞计数,109/ L |
8.85 (6.34,11.83) |
8.46 (6.11,11.19) |
11.40 (8.43,16.26) |
< 0.001 |
| NLR |
6.65 (3.89,10.77) |
6.25 (3.78,9.85) |
9.74 (5.89,14.93) |
< 0.001 |
| PLR |
149.03 (104.31,224.60) |
148.96 (107.43,220.27) |
151.40 (81.96,250.07) |
0.518 |
| 高钙 |
0.54 (0.37,0.82) |
0.51 (0.36,0.76) |
0.75 (0.41,1.12) |
< 0.001 |
| SIRI |
4.51 (2.63,8.44) |
4.19 (2.47,7.39) |
8.41 (4.38,15.27) |
< 0.001 |
| 他们 |
1285.43 (746.84,2247.28) |
1233.05 (735.30,2139.17) |
1923.99 (894.50,2898.80) |
0.003 |
| HB, g / L |
139.00 (123.00,154.00) |
140.00 (124.00,155.00) |
128.00 (115.00,147.00) |
0.001 |
| 加拿大皇家银行,1012/ L |
4.54 (3.98,5.01) |
4.58 (4.05,5.02) |
4.21 (3.71,4.88) |
0.006 |
| PLT,109/ L |
205.00 (161.00,249.25) |
207.00 (164.00,250.00) |
196.00 (138.00,246.50) |
0.113 |
| ALT, U / L |
33.00 (23.00,56.00) |
32.00 (22.25,51.75) |
56.00 (30.00,193.00) |
< 0.001 |
| AST, U / L |
72.00 (36.50,169.5) |
67.00 (35.00,143.00) |
225.00 (73.50,456.00) |
< 0.001 |
| GGT, U / L |
44.00 (27.00,75.00) |
43.00 (27.00,72.75) |
61.00 (29.00,104.00) |
0.007 |
| 包子,更易与L |
6.72 (5.25,9.37) |
6.38 (5.09,8.50) |
10.33 (7.45,13.15) |
< 0.001 |
| 肌酐,umol / L |
101.00 (82.00,128.00) |
98.00 (81.00,119.00) |
134.00 (109.00,174.50) |
< 0.001 |
| 尿酸,umol / L |
484.00 (449.00,542.00) |
481.00 (447.00,535.00) |
523.00 (461.00,637.00) |
< 0.001 |
| 半胱氨酸蛋白酶抑制物C mg / L |
1.22 (0.97,1.58) |
1.17 (0.95,1.49) |
1.65 (1.32,2.18) |
< 0.001 |
| CK, U / L |
507.00 (186.00,1368.75) |
463.50 (172.00,1322.50) |
745.00 (303.25,2012.50) |
0.002 |
| CKMB U / L |
52.00 (25.00,127.00) |
48.00 (24.00,117.25) |
86.00 (33.00,190.00) |
< 0.001 |
| LDH, U / L |
375.00 (266.25,639.75) |
350.50 (255.25,556.75) |
695.50 (407.75,1229.75) |
< 0.001 |
| α-HBDH U / L |
259.00 (173.00,475.00) |
240.00 (165.00,427.50) |
490.50 (273.75,773.00) |
< 0.001 |
| CTnT ng / L |
1014.00 (213.50,3480.00) |
786.95 (185.97,3069.00) |
3077.00 (1133.00,6711.00) |
< 0.001 |
| 法国巴黎,pg / mL |
1022.50 (255.15,3860.75) |
884.90 (204.85,2713.00) |
5349.00 (2058.00,15267.00) |
< 0.001 |
| 葡萄糖,更易与L |
6.66 (5.56,8.66) |
6.52 (5.44,8.19) |
8.47 (6.41,11.60) |
< 0.001 |
| 肌红蛋白,ng / mL |
341.10 (104.50,910.40) |
308.95 (95.96,820.28) |
615.00 (203.50,2251.00) |
< 0.001 |
| 病变血管在过程确认 |
| LM,(%) |
13 (2) |
13 (2) |
0 (0) |
0.233 |
| 小伙子,(%) |
213 (33) |
185 (33) |
28 (31) |
0.836 |
| LCX,(%) |
70 (11) |
62 (11) |
8 (9) |
0.674 |
| RCA,(%) |
157 (24) |
134 (24) |
23日(26日) |
0.819 |
| 风险评估 |
| 优雅,分数 |
125.00 (102.00,154.00) |
121.00 (101.00,146.00) |
178.00 (140.00,206.50) |
< 0.001 |
|
|
